The first generic version of Novartis' ($NVS) transdermal patch for Alzheimer's has launched with hopes of getting a slice of the branded med's approximately $400 ...
- Italfarmaco Group adds innovative Alzheimer’s disease therapy to its neurology-based product portfolio – MILAN & BASEL, Switzerland--(BUSINESS WIRE)--Italfarmaco Group (Italfarmaco) and Luye Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback